{
  "trial_id": "NCT02563327",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age",
      "label": "met",
      "evidence": "30 years old"
    },
    {
      "criterion": "TBTC Study 31 enrollment",
      "label": "met",
      "evidence": "enrolled in TBTC Study 31"
    },
    {
      "criterion": "Randomized to rifapentine treatment regimens",
      "label": "met",
      "evidence": "randomized to receive one of the rifapentine treatment regimens"
    },
    {
      "criterion": "Willingness to be sampled",
      "label": "met",
      "evidence": "willingness to be sampled 6 times during 1 PK sampling session and 2 - 3 times during another PK sampling session at an outpatient clinic, a clinical research center, or a hospital"
    },
    {
      "criterion": "Written informed consent given",
      "label": "met",
      "evidence": "written informed consent given for the Study 31 PK/PD study"
    }
  ],
  "exclusion": [
    {
      "criterion": "Hematocrit < 25% most recent value, measured within 30 days before PK/PD study",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "enrollment",
      "label": "triggers",
      "evidence": ""
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "46",
    "trial_id": "NCT02563327",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}